Takeshi Okada, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lipid Metabolism, Inborn Errors | 2 | 2019 | 123 | 1.160 |
Why?
|
Cholesterol Ester Transfer Proteins | 2 | 2019 | 113 | 1.150 |
Why?
|
Lipoproteins, HDL | 2 | 2020 | 675 | 0.980 |
Why?
|
Probucol | 2 | 2023 | 25 | 0.790 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2021 | 395 | 0.630 |
Why?
|
Chromatography, Gel | 2 | 2021 | 641 | 0.610 |
Why?
|
Lipoproteins | 3 | 2021 | 877 | 0.580 |
Why?
|
Dyslipidemias | 2 | 2021 | 870 | 0.530 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2021 | 1535 | 0.490 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2227 | 0.460 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3803 | 0.430 |
Why?
|
Butyrates | 2 | 2022 | 169 | 0.360 |
Why?
|
Benzoxazoles | 2 | 2022 | 91 | 0.360 |
Why?
|
Atherosclerosis | 3 | 2020 | 3406 | 0.280 |
Why?
|
Hypertriglyceridemia | 2 | 2022 | 292 | 0.270 |
Why?
|
Ketocholesterols | 2 | 2022 | 5 | 0.240 |
Why?
|
Proteomics | 1 | 2019 | 3840 | 0.240 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 609 | 0.230 |
Why?
|
Myocardium | 4 | 2022 | 4746 | 0.210 |
Why?
|
Twins, Monozygotic | 1 | 2024 | 470 | 0.200 |
Why?
|
Receptors, Lipoprotein | 1 | 2022 | 88 | 0.190 |
Why?
|
Diastole | 1 | 2024 | 782 | 0.190 |
Why?
|
Heart Injuries | 1 | 2023 | 206 | 0.180 |
Why?
|
Dermatitis | 1 | 2022 | 202 | 0.180 |
Why?
|
Cholesterol, Dietary | 1 | 2021 | 224 | 0.180 |
Why?
|
Complement C1q | 1 | 2019 | 93 | 0.170 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2018 | 31 | 0.160 |
Why?
|
Acute-Phase Reaction | 1 | 2019 | 91 | 0.160 |
Why?
|
Cardiomyopathies | 2 | 2022 | 2021 | 0.150 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2022 | 242 | 0.150 |
Why?
|
Cholesterol, HDL | 1 | 2024 | 1812 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1838 | 0.140 |
Why?
|
Fenofibrate | 1 | 2017 | 87 | 0.140 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 1061 | 0.140 |
Why?
|
Cardiomegaly | 1 | 2019 | 590 | 0.140 |
Why?
|
Inflammasomes | 1 | 2022 | 526 | 0.140 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11476 | 0.130 |
Why?
|
Myocardial Ischemia | 2 | 2019 | 2133 | 0.130 |
Why?
|
Liver | 2 | 2022 | 7514 | 0.130 |
Why?
|
Complement System Proteins | 1 | 2019 | 737 | 0.130 |
Why?
|
Ketone Bodies | 1 | 2015 | 76 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 2019 | 752 | 0.120 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2380 | 0.120 |
Why?
|
beta Catenin | 1 | 2019 | 1042 | 0.120 |
Why?
|
PPAR gamma | 1 | 2017 | 483 | 0.120 |
Why?
|
Psoriasis | 1 | 2022 | 946 | 0.120 |
Why?
|
Myocytes, Cardiac | 2 | 2019 | 1666 | 0.110 |
Why?
|
Antioxidants | 1 | 2020 | 1667 | 0.100 |
Why?
|
Sodium Bicarbonate | 1 | 2011 | 60 | 0.090 |
Why?
|
3-Iodobenzylguanidine | 1 | 2011 | 115 | 0.090 |
Why?
|
Brugada Syndrome | 1 | 2011 | 93 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2795 | 0.080 |
Why?
|
Contrast Media | 2 | 2012 | 5311 | 0.080 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 22127 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18220 | 0.070 |
Why?
|
Energy Metabolism | 2 | 2018 | 2877 | 0.070 |
Why?
|
Macrophages | 2 | 2021 | 5753 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2131 | 0.070 |
Why?
|
Male | 17 | 2024 | 360693 | 0.070 |
Why?
|
Apolipoproteins E | 1 | 2013 | 1443 | 0.070 |
Why?
|
Glucose | 2 | 2018 | 4342 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2011 | 1030 | 0.070 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1270 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1651 | 0.070 |
Why?
|
Pressure | 2 | 2019 | 1155 | 0.060 |
Why?
|
Heart Conduction System | 1 | 2011 | 1008 | 0.060 |
Why?
|
Mice, Knockout | 5 | 2019 | 14392 | 0.060 |
Why?
|
Mice | 10 | 2023 | 81326 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2011 | 808 | 0.060 |
Why?
|
Middle Aged | 10 | 2024 | 220853 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20119 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1724 | 0.060 |
Why?
|
Female | 12 | 2024 | 392544 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2013 | 4506 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1560 | 0.050 |
Why?
|
Apolipoprotein C-II | 1 | 2022 | 15 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2092 | 0.050 |
Why?
|
Lipoprotein Lipase | 1 | 2022 | 133 | 0.050 |
Why?
|
Animals | 11 | 2023 | 168079 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 2683 | 0.050 |
Why?
|
Diet | 1 | 2019 | 8048 | 0.050 |
Why?
|
Adenosine Triphosphate | 2 | 2018 | 1988 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8702 | 0.040 |
Why?
|
Blood Platelet Disorders | 1 | 2021 | 60 | 0.040 |
Why?
|
Mice, Obese | 1 | 2021 | 418 | 0.040 |
Why?
|
PPAR alpha | 1 | 2021 | 175 | 0.040 |
Why?
|
Adult | 5 | 2024 | 221119 | 0.040 |
Why?
|
Scavenger Receptors, Class B | 1 | 2019 | 85 | 0.040 |
Why?
|
Fibrosis | 2 | 2018 | 2051 | 0.040 |
Why?
|
Aorta | 2 | 2019 | 2040 | 0.040 |
Why?
|
Humans | 13 | 2024 | 761208 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12939 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2021 | 489 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2194 | 0.040 |
Why?
|
Chylomicrons | 1 | 2017 | 26 | 0.040 |
Why?
|
Th1 Cells | 1 | 2023 | 1042 | 0.040 |
Why?
|
Kidney | 1 | 2012 | 7033 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2022 | 891 | 0.030 |
Why?
|
Placebo Effect | 1 | 2021 | 518 | 0.030 |
Why?
|
Registries | 1 | 2012 | 8247 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 2021 | 603 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1097 | 0.030 |
Why?
|
Citrate (si)-Synthase | 1 | 2015 | 48 | 0.030 |
Why?
|
Postprandial Period | 1 | 2017 | 314 | 0.030 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2015 | 72 | 0.030 |
Why?
|
Rats | 2 | 2023 | 23704 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2015 | 185 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2015 | 240 | 0.030 |
Why?
|
Phosphocreatine | 1 | 2015 | 261 | 0.030 |
Why?
|
Cholesterol | 2 | 2013 | 2902 | 0.030 |
Why?
|
Diet, Atherogenic | 1 | 2013 | 92 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6505 | 0.030 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2018 | 854 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16575 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1885 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2024 | 3813 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2023 | 2726 | 0.020 |
Why?
|
Aged | 6 | 2024 | 169288 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3899 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3770 | 0.020 |
Why?
|
Renal Replacement Therapy | 1 | 2012 | 281 | 0.020 |
Why?
|
Heart Failure | 2 | 2013 | 11701 | 0.020 |
Why?
|
Washington | 1 | 2011 | 314 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15637 | 0.020 |
Why?
|
Body Weight | 1 | 2021 | 4618 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5521 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7571 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1376 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5874 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 1989 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2012 | 39126 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5842 | 0.020 |
Why?
|
Heart Atria | 1 | 2011 | 1349 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1490 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 2182 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13511 | 0.010 |
Why?
|
Radiography | 1 | 2012 | 6974 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 80674 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10756 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6387 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18926 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12728 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23416 | 0.010 |
Why?
|
Prospective Studies | 2 | 2011 | 54435 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59221 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10759 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15841 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21365 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 29687 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58952 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 64681 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74239 | 0.000 |
Why?
|